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A B S T R A C T
In the chick embryo, two methods are now used for studying the developmental role of
genes by loss-of-function approaches: vector-based shRNA and morpholino oligonucleo-
tides. Both have the advantage that loss-of-function can be conducted in a spatially and
temporally controlled way by focal electroporation. Here, we compare these two methods.
We find that the shRNA expressing vectors pRFPRNAi, even when targeting a
non-expressed protein like GFP, cause morphological phenotypes, mis-regulation of non-
targeted genes and activation of the p53 pathway. These effects are highly reproducible,
appear to be independent of the targeting sequence and are particularly severe at primitive
streak and early somite stages. By contrast, morpholinos do not cause these effects. We
propose that pRFPRNAi should only be used with considerable caution and that morpholi-
nos are a preferable approach for gene knock-down during early chick development.
 2008 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Sequence specific knock-down strategies using morpho-
lino oligonucleotides and short-interfering RNAs (siRNA) have
proven to be powerful tools to study gene function in different
organisms. However, sequence-independent off-target effects
have been reported in mammals and fish to cause develop-
mental defects including wide spread cell death (Ekker and
Larson, 2001; Robu et al., 2007; Scacheri et al., 2004). The chick
embryo is a well established developmental model system,
which lends itself particularly well to the introduction of
DNA constructs by electroporation into specific tissues to per-
form temporally and spatially controlled gain- and loss-
of-function studies (Funahashi et al., 1999; Katahira and
Nakamura, 2003; Muramatsu et al., 1997; Nakamura et al.,
2004, 2000).
For loss-of-function, electroporation of morpholinos (Kos
et al., 2003; Papanayotou et al., 2008; Sheng et al., 2003; Tucker,
2001; Voiculescu et al., 2007) or expression of dominant nega-
tive DNA constructs (Becker et al., 2001; Bel-Vialar et al., 2002;
Chen and Cepko, 2002) have both been successful. Recently,
methods for vector-based RNA interference have been de-
scribed, requiring small amounts of DNA to be introduced
into tissues, while allowing long lasting and stable expression
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of the short-interfering RNA (Bron et al., 2004; Das et al., 2006;
Katahira and Nakamura, 2003). One approach in particular
used a system to express short-hairpin RNAmolecules, which
resemble naturally occurring microRNA (miRNA) and appear
to be processed efficiently by endogenous enzymes to yield
siRNA and gene silencing (Das et al., 2006). Most studies using
siRNA approaches generally investigate processes that occur
after the 10-somite stage, while morpholino knock-down
has most successfully been used in young embryos before
or around primitive streak stages.
To establish a reliable loss-of-function strategy in young
chick embryos we compared the vector-based approach using
short-hairpin RNAs (shRNA; in particular pRFPRNAi; Das
et al., 2006) with morpholinos. We were surprised to find that
vectors targeting Eya2, Pax2 and Notch1 as well as control
vectors targeting GFP, cause identical morphological pheno-
types including the absence of cranial placodes and neural
tube closure defects, and mis-regulation of neural, preplacod-
al, otic and olfactory placode markers. In addition, elevated
levels of apoptosis are observed. These non-specific effects
appear to be independent of the miRNA pathway member Di-
cer or of activation of the interferon pathway, but seem to be
due to activation of p53 target genes. To determine whether
all antisense methods suffer from the same shortcomings,
we carried out similar experiments using morpholinos and
find that they cause efficient and specific knock-down, but
do not show non-specific side-effects. Our data suggest that
using morpholinos is the preferential approach for gene
knock-down in early (HH4–10) chick embryos.
2. Results
2.1. pRFPRNAi gene silencing vectors affect otic
morphology and gene expression
Because of our interest in ectodermal patterning and sen-
sory placode formation, we focussed on designing knock-
down strategies for genes that are expressed in the placode
territory (Eya2) and the otic placode (Pax2). We started by
using shRNA expression vectors pRFPRNAi (Das et al., 2006)
and used the otic placode, which becomes morphologically
discernible at stage HH10, as a read out.
The Eya2-targeting vector was introduced into stage HH5-
6 embryos. Embryos were incubated overnight, harvested
and tested for Pax2 expression as the earliest otic marker
(Groves and Bronner-Fraser, 2000). RFP+ cells expressing the
Eya2 silencing vector have reduced Pax2 expression and otic
placode morphology is severely disrupted (6/6; Fig. 1A, A 0
and a). To test the efficiency of the silencing vector, we per-
formed in situ hybridisation using a 3 0UTR probe for Eya2.
Surprisingly, expression of the Eya2 silencing vector causes
up- rather than down-regulation of the transcript (6/7;
Fig. 1B, B 0 and b). This unexpected result could be caused
by off-target effects of the Eya2-target sequence in the silenc-
ing vector. To test this, we introduced silencing vectors tar-
geting the otic specific genes Pax2 and cNotch1 (Adam et al.,
1998; Daudet and Lewis, 2005; Groves and Bronner-Fraser,
2000). The Pax2 silencing vector causes disruption of otic
cup morphology and only few cells retain expression of
Pax2 (n = 19/19; Fig. 1C and C 0; Table 1) or the otic markers
BMP7 and GATA3 (13/13 and 10/10, respectively; not shown).
A similar effect is observed when cNotch1 is targeted: cNotch1
expression is reduced (6/6; Fig. 1D and D 0), Pax2 expression (6/
8; Fig. 1E and E 0) and otic morphology is lost (Fig. 1e).
Although these effects may suggest an early role for both
genes in otic development, the loss of Pax2 transcripts and
the otic placode after pRFPRNAi cNotch1 expression is unex-
pected, because previous studies showed that Notch inhibi-
tion by the c-secretase inhibitor DAPT leaves otic structures
largely unaffected (Abello et al., 2007). Furthermore, the con-
sequences of targeting Pax2 and cNotch1 strongly resemble
the effects of the Eya2 silencing vector. Consistent with this,
we also observe an up-regulation of Eya2 after pRFPRNAi Pax2
expression (14/14; not shown).
The above results suggest that the effects of pRFPRNAi
vectors are non-specific. To test this, the presumptive otic
ectoderm on one side of the embryo was electroporated with
a vector targeting GFP (Das et al., 2006) together with pCAb-
IRES-GFP (driving GFP ubiquitously). The contralateral side
of the same embryo received pCAb-IRES-GFP only (Fig. 1F).
The side expressing GFP alone contains fluorescent cells
(Fig. 1F 0) and the otic cup is intact expressing Pax2 (bent arrow
in Fig. 1F00), while the side transfected with both GFP and the
silencing vector shows greatly reduced fluorescence. How-
ever, no Pax2 (0/20; Fig. 1F00 and 1g; Table 1) or cNotch1 (0/5;
not shown) expression is detected and otic morphology is lost
completely (Fig. 1g). In contrast, neither misexpression of vec-
tors encoding GFP or RFP (nP 40 each) nor coexpression of
both fluorescent proteins impaired otic development (n = 5
using pCAGGS vectors; nP 60 using pCAb-IRES vectors).
To rule out the possibility that the phenotypes observed
are specific to otic markers and morphology, we investigated
whether the silencing control vector pRFPRNAi GFP also alters
the expression of preplacodal, neural plate and placodemark-
ers (Table 1). We observe ectopic expression of Sox3 (14/19;
Fig. 2E and E 0), Six1 (7/11; Fig. 2D and D 0), Six4 (8/14; Fig. 2F,
F 0 and f), and RALDH3 (3/7; not shown) and occasionally, with
the exception of Sox3, loss of endogenous gene expression.
Reduced Sox2 expression in the neural plate appears to be a
consequence of changes in neural tube morphology rather
than loss of gene expression (Fig. 2C, C 0 and c). Finally, we
see down-regulation of Eya2 expression (Fig. 2B, B 0 and b)
when using a full length – rather than a 3 0UTR-antisense
probe (Fig. 2A, A 0 and a). We cannot fully explain the discrep-
ancy between the results when using two different Eya2
probes. We can rule out hybridisation of the 3 0UTR probe to
sequences in the electroporation vector: probes for Dlx5
3 0UTR, Eya2 FL and 3 0UTR, GnRH1, cNotch1, Pax2 30UTR and
FL, Sox2 and Sox3 were synthesised using the same plasmid
template and include the same or similar sequences between
the RNA polymerase promoter and themultiple cloning site of
the template vector. Following pRFPRNAi electroporation,
only some of these genes are up-regulated, while others are
not. This excludes the possibility that the results are due to
binding of the probes to the vector sequences. One possible
explanation is that by introducing the silencing vectors short
transcripts are created to which the shorter Eya2 3 0UTR, but
not the longer Eya2 FL probe can bind. All phenotypes de-
scribed are independent of the silencing vector concentration
being still observed with as little as 300 ng/ll vector. At this
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concentration vector-based RFP expression can barely be de-
tected (Fig. 2E).
2.2. Morpholino oligonucleotides do not cause non-specific
effects
The above results suggest that pRFPRNAi vectors cause
non-specific effects. To test whether this is the case for other
antisense methods for knocking-down gene expression, we
designed two morpholinos targeting intron–exon boundaries
of Eya2 and two morpholinos targeting Pax2. Both Eya2 mor-
pholinos were electroporated simultaneously into stage
HH4–5 embryos, targeting the presumptive otic epithelium
(Garcia-Martinez et al., 1993; Streit, 2002). Their efficiency
and specificity was confirmed by RT-PCR of electroporated tis-
sues (Fig. 3A). Neither morpholinos targeting Eya2 (n = 18) nor
control (n = 14) morpholinos affect the expression of Pax2 or
otic morphology (Fig. 3B). Electroporation of the Pax2
Fig. 1 – Expression of gene silencing vectors causes loss of otic markers and otic cup morphology, independent of the target
sequence. (A, A 0) Expression of Eya2 pRFPRNAi as revealed by the presence of RFP (A 0) causes down-regulation of otic Pax2
expression (arrowhead, A and transverse section a). (B, B 0). Up-regulation of Eya2 rather than loss of expression is observed
after misexpression of the Eya2 pRFPRNAi vector (arrowhead in B, B 0; transverse section b). In A and B black bars indicate level
of sections shown in a and b. (C–E 0) Expression of silencing vectors targeting Pax2 (C 0, red) and cNotch1 (D 0, E 0, red) results in
loss of Pax2 and cNotch1 expression (arrowheads in C–E). Down-regulation of otic markers is accompanied by loss of otic cup
morphology (arrowhead in E and e). (F–g) GFP expressing vector was electroporated together with a GFP silencing pRFPRNAi
into the presumptive otic territory on one side of the embryo (F, left; F 0, magenta and white), while the contralateral side was
electroporated with GFP expressing vector only (F, right; F 0, green). Otic tissue expressing GFP alone shows normal placode
morphology and Pax2 expression (bent arrow in F00). GFP expression is reduced where GFP expressing and GFP silencing
vectors were coelectroporated (F 0, F00). Additionally, Pax2 expression is lost, no otic placode is visible (arrowhead in F00 and g)
and neural tube closure is impaired (* in g). Side-effects can be observed irrespective of concentrations used for
electroporations (A 0, B 0 and F 0, 1 lg/ll; C 0 and D 0, 0.5 lg/ll; E 0, 0.3 lg/ll). ap, area pellucida; ao, area opaca. The section planes in
e and g are indicated by small bars in E and F00, respectively.
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morpholinos individually or combined efficiently reduces Pax2
protein as determined by antibody staining (Fig. 3D–D00, F and
G00), while cells carrying sense or standard controlmorpholinos
express Pax2 normally (Fig. 3E–E00 and H–H00). In addition, loss
of Pax2 leads to thinning of the otic placode suggesting that
Pax2may be required for its normalmorphology.We expanded
this analysis to other molecular markers and find that, unlike
misexpression of pRFPRNAi vectors, electroporation of Eya2 or
Pax2 morpholinos does not lead to ectopic up-regulation of
Eya2 (Eya2-MO: n = 9; Pax2-MO: n = 8), Six1 (Eya2-MO: n = 15;
Pax2-MO: n = 7), Pax6 (Eya2-MO: n = 10; Pax2-MO: n = 4), Six4
(Eya2-MO: n = 8) or Sox3 (Pax2-MO: n = 6; Fig. 3C and C 0).
Table 1 – Effects after electroporation of gene silencing vectors or morpholinos into early chick embryos
Ectopic expression No effect Loss of expression n
ISH probe
pRFPRNAi Eya2
Eya2 3 0UTR 6 1 0 7
Pax2 0 0 6 6
pRFPRNAi Pax2
Pax2 0 0 19 19
BMP7 0 0 13 13
GATA3 0 0 10 10
Eya2 3 0UTR 14 0 0 14
Eya2 FL 0 2 5 7
pRFPRNAi Notch1
Notch1 0 0 6 6
Pax2 0 2 6 8
pRFPRNAi GFP
Eya2 3 0UTR 22 0 0 22
Eya2 FL 0 7 7 14
Sox2 0 5 16* 21
Sox3 14 5 0 19
Six1 7 4 2 11
Six4 8 6 2 14
Pax2 0 0 20 20
Pax2 3 0UTR 0 0 7 7
Notch1 0 0 5 5
RALDH3 3 2 2 7
GnRH 0 27 1 28
Dlx5 3 0UTR 0 5 0 5
TUNEL staining Cell death No cell death Unrelated cell death
12 7 7 26
ISH/Ab probe
Eya2 morpholino
Eya2 FL 0 9 0 9
Six1 0 15 0 15
Six4 0 8 0 8
Pax2 0 18 0 18
Pax6 0 10 0 10
Pax2 morpholino
Eya2 3 0UTR 0 8 0 8
Eya2 FL 0 6 0 6
Six1 0 7 0 7
Sox3 0 6 0 6
Pax2 0 0 12 12
Pax6 0 4 0 4
Dicer morpholino
Eya2 3 0UTR 0 13 0 13
Eya2 FL 0 17 0 17
Pax2 0 6 0 6
pCAb-IRES-GFP/RFP
Pax2 0 P60 0 P60
TUNEL staining Cell death No cell death Unrelated cell death
0 8 3 11
Electroporation of different gene silencing vectors causes ectopic expression and/or loss of preplacodal, placodal or neural markers. These
effects are not observed when morpholinos or vectors ubiquitously expressing GFP and/or RFP are electroporated. Ab, antibody; * the apparent
loss of Sox2 expression is due to impaired neural tube closure. Unrelated cell death refers to embryos, where elevated apoptosis was observed
outside the electroporated area.
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Taken together, the above results indicate that morpholi-
nos can be used for specific knock-down of gene function in
early chick embryos, whereas pRFPRNAi vectors cause non-
specific effects including up- and down-regulation of head
ectoderm markers and defects in otic placode formation.
2.3. Expression of Dicer, Drosha and Argonaute2
The RNA interference system used allows optimal pro-
cessing of the expressed transcripts by the endoribonuc-
leases Drosha and Dicer (Das et al., 2006), which should
yield better silencing efficiency than conventional RNAi
approaches (Chang et al., 2006). If these enzymes are not
expressed in relevant tissues, the overexpressed transcripts
may be processed inappropriately or not at all, which in
turn can result in unspecific cellular responses (Sledz
et al., 2003). To test whether this might be the cause of
the non-specific effects observed, we analysed the expres-
sion patterns of both endoribonucleases and a component
of the RNA-induced silencing complex (RISC) Argonaute2
(Hammond et al., 2001) between stages HH5 and HH12.
At neural plate stages (HH5–HH7, Fig. 4), Dicer and Drosha
are strongly expressed throughout the ectoderm and weakly
in the mesoderm, but appear to be absent from the endoderm
Fig. 2 – Side-effects caused by the expression of gene silencing vectors. The expression of silencing vectors targeting GFP
causes up-regulation (black arrowheads in a and f) or down-regulation (white arrowhead in b) of the PPR markers Eya2 (A, A 0,
a, B, B 0, b), Six4 (F, F 0, f) and Six1 (D, D 0) and the neural marker Sox3 (E, E 0). The apparent loss of the neural marker Sox2 (C, C 0, c)
is due to malformation of the neural tube (*, see also b and Fig. 1g). Note that expression of the GFP silencing vectors causes
up-regulation of Eya2 if tested with an in situ hybridisation probe against the 3 0UTR (3 0Eya2 in A 0), but a loss of Eya2 when
using a full length probe (FLEya2 in B 0). All embryoswere incubated for 6 h after electroporation and therefore show only weak
reporter RFP expression (A–F; insets show RFP fluorescence and bright field image for orientation). Bars indicate section
planes.
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(Fig. 4A–b0 0 0 and D–e 0 0 0). Likewise, Argonaute2 is detected
throughout the ectoderm in stage HH5–7 embryos (Fig. 4C–c 0 0 0
and F–f 0 0 0) but is absent from both mesoderm and endoderm.
At placode stages (HH9–10) Dicer is expressed in the neural
tube, neural crest cells and weakly in the head ectoderm
(Fig. 4G, g 0–gv) as well as in the prechordal (Fig. 4g 0 and g00),
somitic (Fig. 4gv) and lateral plate mesoderm (Fig. 4g 0v) and
the developing heart (Fig. 4g 0 0 0). Dicer is not present in the
notochord or paraxial head mesoderm (Fig. 4g 0–g 0 0 0). The
expression of Drosha and Argonaute2 differs substantially
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from Dicer (Fig. 4G–iv). Both are detected exclusively in the
ventral and lateral aspects of the neural tube and faintly in
the open neural plate. No expression is observed in the meso-
derm or endoderm.
Differential expression of Dicer, Drosha and Argonaute2 is
also observed at stage HH12 (Fig. 4J–kv
0
). Dicer transcripts are
found in the otic cup and the ectoderm ventral to it
(Fig. 4j 0v), in the neural tube with strongest expression dor-
sally (Fig. 4j 0–jv 0), in the optic vesicle (Fig. 4j 0) and in migrating
neural crest cells (Fig. 4j00, j 0 0 0 and 4jv). Furthermore, Dicer
expression can also be seen in the ventral wall of the foregut
(Fig. 4j 0 0 0–jv), the heart (Fig. 4jv) and weakly in the dermomyo-
tome (Fig. 4jv 0), while it remains absent from the head meso-
derm (Fig. 4j 0–j 0 0 0). In contrast, expression of both, Drosha
(Fig. 4K–kv 0) and Argonaute2 (not shown) can only be detected
in the ventral and lateral neural tube, the optic stalks and
weakly in the developing heart.
Thus, while Dicer is expressed in all tissues where gene
silencing vectors were tested, Drosha and Argonaute2 are only
present in preplacodal ectoderm and the neural tube. It has
been proposed that Dicer is the limiting factor in the RNAi
pathway (Duchaine et al., 2006; Mikuma et al., 2004) and that
it can associate with distinct classes of RISC to repress mRNA
expression (Forstemann et al., 2007; Okamura et al., 2004;
Tomari et al., 2007). Hence, the finding that Dicer is expressed
in the relevant tissues suggests that absence of this enzyme is
not the reason for the non-specific effects of the gene silenc-
ing vectors.
2.4. Side-effects caused by pRFPRNAi expression are
independent of Dicer activity
It is possible that transcripts from the ectopically
expressed gene silencing vectors compete with endogenous
small RNAs for processing by Dicer. If Dicer is the limiting fac-
tor in the RNAi pathway (Duchaine et al., 2006; Mikuma et al.,
2004), expression of the gene silencing vectors may lead to
insufficient processing of endogenous substrates and the ab-
sence of miRNAs that normally keep specific genes silent. As
a consequence, changes in unrelated transcripts may be
observed. To test this hypothesis we investigated whether
morpholino-mediated knock-down of Dicer leads to mis-reg-
ulation of gene expression. Embryos electroporated with mor-
pholinos that interfere with Dicer splicing events (Fig. 5C) were
examined for Eya2 or Pax2 expression. Unlike the striking ef-
fects observed after electroporation of silencing vectors,
reduction of Dicer did not affect Eya2 (Fig. 5A, A 0 and a for
Eya2 3 0UTR, 13/13; Fig. 5B, B 0 and b for Eya2 full length, 17/
17) or Pax2 expression or otic cup morphology (6/6; not
shown). It is therefore unlikely that the expression of the gene
silencing vectors results in up- or down-regulation of gene
expression by sequestering endogenous Dicer. Moreover,
these results support the previous findings that electropora-
tion of morpholinos in general does not cause similar side-
effects.
We further tested whether the expression of the gene
silencing vectors affects Dicer expression levels: no changes
were observed by RT-PCR (Fig. 5D, control primers) or by
in situ hybridisation (not shown). To assess whether the
side-effects observed are dependent on Dicer activity, we
electroporated GFP silencing vectors together with Dicer mor-
pholinos. However, all embryos transfected with both silenc-
ing tools showed the characteristic unspecific phenotypes
described above (10/10; not shown). These results suggest that
the side-effects caused by the pRFPRNAi expression are not
due to competition for Dicer.
2.5. Interferon responsive genes are unaffected by
pRFPRNAi GFP expression
The interferon pathway functions as an initial defence
mechanism against viral infection. Activation of this innate
immune response is triggered partly by dsRNA, a common vir-
al replicative intermediate (Sledz et al., 2003). The resulting
signalling cascade is mediated by a variety of proteins culmi-
nating in the induction of interferon-stimulated genes (ISGs;
Pebernard and Iggo, 2004; Sledz et al., 2003; Witting et al.,
2008). Although unspecific activation of the interferon system
through expression of silencing RNAs has so far not been re-
ported in chick, in mammalian cells ISGs can be activated
independently of interferon ligand (Sledz et al., 2003; Sledz
and Williams, 2004). p56 and FGF2 are two classic ISGs that
Fig. 3 – Morpholino mediated knock-down in early chick embryos. (A) Two different morpholinos were used to reduce Eya2
expression by targeting exon–intron boundaries: the first morpholino results in the deletion of exon 3, revealed by an
amplicon 49 bp smaller than wild type (top row, lane 1). The secondmorpholino causes excision of exon 6 resulting in a band
68 bp smaller than wild type (top row, lane 5). The wild type transcripts in both lanes originate from Eya2 morpholino-free
cells that were isolated together with Eya2 morpholino containing cells. This is unavoidable, since electroporation results in
mosaic misexpression. Deletion of exons is not seen with control morpholinos (top row, lanes 3 and 7). Morpholinos do not
affect the expression of the housekeeping gene cS17 (bottom row). +, RNAwith reverse transcriptase; , reverse transcriptase
free control. (B) Both Eya2 morpholinos were electroporated into the future otic territory at stage HH5 and the expression of
Pax2 (blue) determined at stage HH11. Cells carrying the morpholinos were visualised by anti-Fluorescein antibodies (brown).
No effect on otic placode formation was observed (arrowhead). (C, C 0) Morpholinos targeting the ATG of Pax2 (fluorescent cells
in C; see also D–D00) do not lead to up-regulation or loss of Sox3 (C 0); inset: overlay of fluorescent and bright field image. (D–D00,
F–G00) Two different morpholinos were used to reduce Pax2 expression: the first morpholino disrupts translation initiation of
Pax2 by targeting the translational start site of the transcript. The secondmorpholino was designed to interfere with splicing
events at the exon 2–intron 3 boundary. Antibody staining against Pax2 reveals that both morpholinos effectively knock-
down Pax2 (arrowheads in D–D00 and F–F00; Pax2ATG MO, ATG targeting morpholino; G–G00; Pax2Exon2 MO, exon 2–intron 3
targeting morpholino). (E–E00, H–H 0 00) Loss of Pax2 is not seen when sense control morpholinos are applied. op, otic placode;
MO, morpholino. The bracket in B shows the area depicted in D–E00; Bars in D and E 100 lm.
b
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Fig. 4 – Expression patterns of Dicer, Drosha and Argonaute2. Expression of Dicer (A, D, G, J), Drosha (B, E, H, K) and Argonaute2
(C, F, I) is shown for stages HH5 (A–C), HH7+ (D–F), HH9–10 (G–I). Expression at stage HH12 is shown for Dicer (J) and Drosha (K).
Expression of Argonaute2 is almost identical to that of Drosha at this stage (not shown). Section planes are indicated by small
arrows. For details see text. 1, Hensen’s node; 2, ectoderm; 3, mesoderm; 4, endoderm; 5, primitive grove; 6, neural plate; 7,
head mesoderm; 8, neural tube; 9, notochord; 10, neural crest cells; 11, head ectoderm; 12, prechordal mesoderm; 13, heart;
14, somite; 15, lateral plate mesoderm; 16, optic vesicle; 17, optic stalk; 18, dermomyotome; 19, otic cup.
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are up-regulated following ds/shRNA treatment (Sledz and
Williams, 2005).
Using a RT-PCR approach we examined the expression of
p56 and FGF2 in chick tissue electroporated with the gene
silencing vector pRFPRNAi GFP or the control vector pCAb-
IRES-RFP. Amplicons for both transcripts are first detectable
after the same number of PCR cycles irrespective of the vec-
tor. However, rather than up-regulation of p56 or FGF2 in the
presence of the gene silencing vector we observed a slight
reduction when compared with tissues expressing the control
vector (Fig. 5D). These results suggest that electroporation of
the gene silencing vectors is unlikely to activate the inter-
feron-stimulated genes p56 and FGF2.
2.6. pRFPRNAi GFP expression activates the p53 pathway
and causes increased apoptosis
It has previously been reported that siRNA in mammalian
cells and morpholinos in zebrafish (Robu et al., 2007; Scacheri
et al., 2004) show off-target effects that lead to activation of
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the p53 pathway and increased apoptosis. We therefore inves-
tigated whether expression of pRFPRNAi GFP induces apopto-
sis using the TUNEL method. About 50% of pRFPRNAi GFP
electroporated embryos show an accumulation of cells under-
going apoptosis (12/26; Fig. 6B and B 0). In contrast, when em-
bryos expressing the control vectors pCAb-IRES-RFP (n = 11,
Fig. 6A and A 0), pCAGGSeGFP (n = 5, not shown) or the pRFPR-
NAi backbone alone (n = 7, not shown) were analysed, no en-
hanced apoptosis was detected in electroporated tissues.
In the absence of cellular stress, p53 protein is expressed
at low steady-state levels and exerts little, if any, effect on cell
fate (Ashcroft et al., 2000; Wang et al., 2003). However, cellular
stress can enhance its stability resulting in the accumulation
of p53 protein (Bellamy et al., 1995; Hainaut, 1995; Yonish-
Rouach, 1996). We therefore analysed p53 expression in
pRFPRNAi GFP expressing tissue. We find that while low level
of p53 protein is found in most cells, high expression levels
are present in cells containing the GFP targeting pRFRNAi vec-
tor (Fig. 6C–C00). In contrast, expression of the pRFPRNAi vector
backbone alone (0/7, Fig. 6E–E00), morpholinos (0/5, not shown)
or pCAGGSeGFP (0/5, not shown) does not result in p53 accu-
mulation. RT-PCR analysis of tissue electroporated with
pRFPRNAi GFP, pCAb-IRES-RFP, standard control or Eya2 mor-
pholinos shows that the p53 target genes PIG3 (Flatt et al.,
2000; Polyak et al., 1997), chick MDM2 (CDM2; LaFleur et al.,
2002) and CIP1/p21 (Rahman-Roblick et al., 2007; Riley et al.,
2008) are up-regulated in the presence of pRFPRNAi GFP, but
not in any other tissue (Fig. 6D). These results suggest that
the morphological defects and gene mis-regulation observed
with pRFPRNAi vectors is due to activation of the p53 path-
way, which leads to apoptosis via PIG3 and CDM2 (Bose and
Ghosh, 2007; Contente et al., 2002; LaFleur et al., 2002; Polyak
et al., 1997) and cell cycle arrest via CIP1/p21 (Sherr and Rob-
erts, 1995; Waldman et al., 1995).
3. Discussion
Here we have evaluated different sequence-specific knock-
down strategies in young chick embryos. We find that pRFPR-
NAi vectors, which use the cell intrinsic miRNA processing
machinery to produce silencing RNAs cause non-specific, off-
target effects. Their expression inchickectodermresults in tar-
get independentmis-regulationof geneexpressionand inmor-
phological defects. Our results propose that activation of the
p53 pathway is at least partially responsible through induction
of CIP1/p21 and the pro-apoptotic genes CDM2 and PIG3. In
contrast, morpholinos specifically reduce gene expression,
but do not cause non-specific effects observed with pRFPRNAi
vectors. Our data suggest that morpholinos are preferable for
knock-down experiments in early chick embryos.
3.1. Involvement of the Dicer pathway?
The gene silencing system introduced by Das and col-
leagues (2006) was designed to allow processing of vector-de-
rived transcripts by the same cellular machinery that is
required for the processing of endogenous miRNA transcripts.
The major components of this pathway include the ribonu-
clease-III family enzymes Drosha and Dicer, the nuclear ex-
port proteins Exportin-5 and RanGTP, and the RISC
component Argonaute2. In the multi-step process yielding
the mature miRNA, primary miRNA precursors (pri-miRNA)
are first converted to pre-miRNA through cleavage by Drosha
within the nucleus. Exportin-5 and RanGTP export pre-miRNA
into the cytoplasm, where Dicer cuts it into 18–22 nt duplexes.
One strand of the mature miRNA now enters the protein
effector RISC, which mediates the degradation or translation
inhibition of mRNA targets (Carrington and Ambros, 2003;
Murchison and Hannon, 2004; Pillai, 2005). The shRNA tran-
scripts of the gene silencing vector are thought to undergo
the same enzymatic cleavage described above to yield better
silencing efficiency than expression of conventional double
stranded RNA silencing molecules (Chang et al., 2006). How-
ever, if any of the major pathway members are not present,
exogenous shRNA may be processed inappropriately and
cause toxic effects. This possibility is unlikely, since we show
that the three main effectors of the miRNA pathway, Dicer,
Drosha and Argonaute2, are expressed in the ectoderm of stage
HH5–HH8 embryos.
At later stages, only Dicer is expressed in all tissues studied
(otic placode, otic cup and neural tube), while Drosha and Arg-
onaute2 are only detected in the neural tube. While it is possi-
ble that Drosha and Argonaute2 proteins remain stable once
expressed in the early ectoderm (HH5–8), it is equally likely
that at later stages Dicer associates with a different RISC to
repress mRNA expression (Forstemann et al., 2007; Okamura
et al., 2004; Tomari et al., 2007). Nonetheless, our results sug-
gest that components of the miRNA pathway are differen-
tially expressed, which should be taken into account when
designing shRNA-mediated knock-down experiments.
We speculated that Dicer may be expressed at a rate-lim-
iting level, and that introduction of the vectors may cause
Fig. 5 – Phenotypes caused by electroporation of pRFPRNAi vectors cannot be mimicked by altered Dicer expression and are
not a consequence of IFN pathway activation. (A and B) Embryos electroporated with Dicer morpholino (brown) do not show
any changes in Eya2 expression (blue; A, A 0, a: 3 0UTR probe; B, B 0, b, full length probe) unlike embryos expressing gene
silencing vectors (compare Figs.1B and 2A, B). Small bars in A 0 and B 0 indicate the level of the sections shown in a and b,
respectively. Arrowheads indicate cells that carry Dicer morpholino and express Eya2 at levels comparable to the non-
electroporated control side. (C) The standard control morpholino (CoMo) does not change the size of the Dicer amplicon (lane
2). In contrast, Dicer morpholinos lead to the excision of exon 8 as determined by the presence of a band 169 bp smaller than
the wild type amplicon (lane 4). Neither morpholino affects the expression of the housekeeping gene cS17 (lanes 5–8). Lanes
1, 3, 5 and 7 show control RNAwithout reverse transcriptase. (D) Expression of pRFPRNAiGFP in early chick embryos does not
lead to an increase of the interferon responsive genes p56 and FGF2, but may slightly decrease their expression compared to
control tissue. Expression of the interferon pathway unrelated Dicer is unchanged under either experimental condition
(Control). The bottom row shows the amplification of Dicer using cDNA from non-electroporated embryos as template.
b
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competition with endogenous miRNA processing events that
require this enzyme. However, Dicer knock-down with a mor-
pholino does not mimic the consequences of gene silencing
vectors, and the vectors themselves do not affect Dicer expres-
sion. Taken together, these results suggest that the non-spe-
cific effects of pRFPRNAi vectors are independent of the
Dicer pathway.
3.2. Involvement of the interferon pathway?
Although the interferon pathway has been implicated in
mammalian innate immune response to small interfering
RNA (Judge and Maclachlan, 2008; Sledz et al., 2003), similar
effects have so far not been described in the chick (Chesnutt
and Niswander, 2004). Our results do not provide support for
the idea that ligand-independent activation of this pathway
is a major cause of the non-specific pRFPRNAi effects. The
expression of twomajor interferon responsive genes is not in-
creased in tissues electroporated with the gene silencing vec-
tor. Recent studies reported that siRNA transfection results in
the induction of only a subset of the 850 putative interferon-
stimulated genes (Sledz et al., 2003). Since we do not know all
of the responsive genes, the possibility of interferon mediated
responses to pRFPRNAi expression cannot be excluded.
Fig. 6 – Electroporationof the gene silencing vector pRFPRNAi results in elevated levels of apoptosis, p53 stabilityandactivation
of p53 targets. (A and B) Cells expressing the gene silencing vector (B, red) undergo apoptosis (B 0), while cells expressing RFP
alone do not (A, red; A 0). (C–C00). Electroporation of pRFPRNAi (visualised by expression of reporter RFP, C and C00, magenta) is
accompanied by higher levels of p53 protein (arrowheads inC andC 0, green; n = 4). An accumulation of p53 is not observed after
electroporation of the pRFPRNAiC vector backbone (E–E00; n = 7). (D) Electroporation of gene silencing vectors into early chick
embryos leads to increasedexpressionof thep53 targetgenesCIP1/p21,PIG2andCDM2whencompared to tissueexpressingRFP
or morpholino (faint bands can already be discerned after 30 PCR cycles, stronger bands are clearly visible after 35 PCR cycles).
The expression of p53 pathway unrelated Dicer under either experimental condition is shown in the bottom row (Control).
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3.3. p53 activation and cell death as a consequence of
pRFPRNAi vector expression
Previous studies have demonstrated off-target effects
caused by introduction of siRNA and morpholinos in different
experimental systems. In zebrafish, about 15% of morpholi-
nos have been reported to cause neural cell death, which in
turn is attenuated by p53 knock-down (Ekker and Larson,
2001; Robu et al., 2007), suggesting that activation of the apop-
totic pathway via p53 is involved in mediating such effects.
Likewise, siRNA can cause changes in untargeted proteins like
p53 and p21 (Scacheri et al., 2004). Our results show that in
young chick embryos introduction of pRFPRNAi vectors tar-
geting a variety of genes including GFP leads to morphological
defects, increased apoptosis, the stabilisation of p53 protein
and the activation of its targets CDM2, PIG3 and CIP1/p21.
CDM2 and PIG3 are known mediators of the apoptotic path-
way (Bose and Ghosh, 2007; Contente et al., 2002; LaFleur
et al., 2002; Polyak et al., 1997) and their activation is likely
to account for the increased cell death observed. However,
this increase does not appear to be sufficient to account for
the complete loss of otic morphology and the dramatic
changes in gene expression. We therefore suggest that in
addition CIP1/p21-mediated cell cycle arrest is responsible
for the non-specific effects observed.
4. Conclusion
Unlike pRFPRNAi, the morpholinos tested in this study do
not show non-specific side-effects or activation of the p53
pathway. We have used five different morpholinos to alter
the processing of newly synthesised transcripts (Schmajuk
et al., 1999). Two of them were designed to interfere with
splicing events at different exon–intron boundaries of the pri-
mary mRNA of the nuclear factor Eya2. Another morpholino
was designed to target splicing events in Dicer transcripts
causing a frame-shift and generating a premature stop codon.
Finally, Pax2 morpholinos targeted both the transcription
start site and intron–exon junction. The use of fluorescein-
conjugated morpholinos allows their visualisation within
cells immediately after electroporation (and also appears to
be required for successful electroporation; Voiculescu et al.,
2008). Although the morpholino is diluted due to cell division
and disposal from cells (Heasman, 2002), we were able to de-
tect strong fluorescence for at least 24 h after electroporation.
The morpholinos used in this study showed effective excision
of the targeted exons, did not affect other transcripts or cell
survival, nor was exon excision observed using standard con-
trol or sense morpholinos. Although we have not systemati-
cally tested the difference between pRFPRNAi or morpholino
based knock-down strategies at later stages, we find that
introduction of pRFPRNAi silencing vectors in the neural tube
of HH11–12 embryos causes transcript mis-regulation similar
to the effects observed in young embryos (Fig. S1). This obser-
vation suggests that the vector-based silencing system needs
to be accompanied by careful controls also at later stages. In
summary, we conclude that morpholinos are effective and
specific and represent the preferred approach for knock-down
studies in young chick embryos.
5. Experimental procedures
5.1. Embryo culture and electroporation
Fertile hens’ eggs (Winter Egg Farm, Hertfordshire, UK)
were incubated in a humidified incubator at 38 C and staged
according to Hamburger and Hamilton (HH; Hamburger and
Hamilton, 1951). Expression-vectors and fluorescein-coupled
Table 2 – List of oligoprimers used in RT-PCR experiments
Gene Accession No. Primer pair
Eya2 (E3–I4) ENSGALG00000004508 F: TCACCCAGCCTGACTGTAAA
R: GAAGGGCTGATGCTGTTTGT
Eya2 (E6–I7) ENSGALG00000004508 F: TGCTGCATACACTGCCTACC
R: ATCCGACCCTCTGTGATGTC
Dicer (E8–I9) NP_001035555.1 F: GCAAGTGTCAGCTGTCAGGA
R: ATTTGCGCAAGATTTCAAGC
FGF2 NM_205433 F: ATTGCTGGCACTGAAATGTG
R: AGCTTTCGTTCCAGGTCCAG
P56 XM_426294 F: GGTGGTGGCTGTGAAAAAGT
R: GGCTCTCCTGTGAGCATTTC
cS17 X07257 F: AGAAGGCGGCGCGGGTGATCATCG
R: GTTTATTGTAAAAGCAACATAACG
PIG3 ENSGALT00000026619 F: TGTGCTGCCGTATTTCTCTG
R: GGGTGTTTTCACTGGCATTT
CIP1/p21 NM_204396.1 F: GGAAGGGACTGAGGAGGACT
R: GTGAGGCTCTGAGGGTTCTG
CDM2 AF005045 F: CAATCAACAAGACTCTACGCTGGCTG
R: TCATCTTCATCTGTGAGCTCCTGTCC
F, forward primer; R, reverse primer. All primer sequences in 5 0–3 0 orientation.
12 M E C H A N I S M S O F D E V E L O P M E N T x x x ( 2 0 0 8 ) x x x –x x x
Please cite this article in press as: Mende, M. et al., Speciﬁc and eﬀective gene knock-down in early chick embryos using
morpholinos but not pRFPRNAi vectors ..., Mech. Dev. (2008), doi:10.1016/j.mod.2008.08.005
ARTICLE IN PRESS
morpholinos were introduced into stage HH11 embryos using
in ovo electroporation or into stage HH 4–6 embryos main-
tained in New culture (New, 1955; Stern and Ireland, 1981)
using an electroporation chamber (McLarren et al., 2003).
For in ovo electroporation eggs were windowed and in-
jected with Indian ink (1:20) to reveal the embryo. Approxi-
mately 0.5 ll of gene-specific or control RNAi vector (1 lg/ll
in 6% sucrose containing 0.1% fast green) was injected into
the lumen of the anterior neural tube. A current of 25 V (5
pulses, 25 ms duration, 1 s interval) was applied across elec-
trodes placed 3–4 mm apart on either side of the embryo
using an IntraCel ISS10 pulse generator. After electroporation
windows were sealed with insulation tape and the eggs incu-
bated for 20 h.
Stages 4–6 embryos attached to the vitelline membrane
were placed into an electroporation chamber (McLarren
et al., 2003) and approximately 0.5 ll vector DNA (1 lg/ll in
6% sucrose containing 0.1% fast green) or morpholino
(0.7 lM in 6% sucrose, 0.1% fast green containing 50 ng/ll
pCAb-IRES-RFP DNA as ‘carrier’) was introduced between
the vitelline membrane and the ectoderm. Using an IntraCel
ISS10 pulse generator a current of 6 V (4 pulses, 50 ms dura-
tion, 1 s interval) was applied across the electrodes. After
electroporation, embryos were maintained in New culture
for 6–15 h at 38 C in a humid atmosphere.
After incubation, embryos were fixed in phosphate-buf-
fered saline (PBS) containing 4% paraformaldehyde and
2 mM EGTA for 4 h at room temperature before processing
for in situ hybridisation.
5.2. Whole mount in situ hybridisation, immunohisto-
chemistry and TUNEL
Embryos were processed for whole mount in situ hybridisa-
tion using digoxigenin (DIG)-labelled antisense RNA probes as
previously described (Streit et al., 1998). The DIG-labelled anti-
sense riboprobes were generated from linearised plasmids
encoding chick Argonaute2 (ChEST 531J17, ARK-Genomics,
UK; Boardman et al., 2002), BMP7 (Liem et al., 1995), Dicer
(ChEST716m22, ARK-Genomics), Dlx5 (Ferrari et al., 1995),
Drosha (ChEST1000b6, ARK-Genimics), Eya2 (Mishima and
Tomarev, 1998), GATA3 (Sheng and Stern, 1999), GnRH (a gift
from Dr. Ian Dunn), Notch1 (Myat et al., 1996), Pax2 (a gift
from M. Goulding), RALDH3 (a gift from Malcolm Maden),
Six1 (a gift from Gillermo Oliver), Six4 (Esteve and Bovolenta,
1999), Sox2 and -3 (a gift from Paul Scotting). NBT/BCIP
(Roche, Switzerland) were used as substrates to detect tran-
scripts. Stained embryos were photographed using an Olym-
pus SZX12 stereomicroscope and an AxioCamHR digital
camera (Zeiss, Germany).
Morpholinos were detected by fluorescence or by using
horseradish peroxidase (POD) conjugated monoclonal anti-
bodies against fluorescein (Roche), while GFP expressing cells
were revealed using polyclonal anti-GFP antibodies (1:1000;
Molecular Probes). Immunofluorescence on whole mounts
and cryosections was performed as previously described
(Bhattacharyya et al., 2004; McLarren et al., 2003), using poly-
clonal antibodies against mouse Pax2 (1:50; Zymed), monoclo-
nal antibodies against Pax3, Pax6 (both Developmental
Hybridoma Bank; 1:20) and p53 (Mab240 and Mab241, applied
simultaneously, 1:100). Immunofluorescence staining with
p53 was performed as described in Krinka et al., 2001. The
appropriate Alexafluor 488 (Molecular Probes) and Cy5 (Invit-
rogen) secondary antibodies were used in a 1:1000 dilution;
nuclei were stained by DAPI (Molecular Probes). Cryosections
were examined and photographed using a Zeiss Axiovert
200M, ORCA digital camera (Hamamatsu) and SimplePCI soft-
ware (Digital Pixel, UK) or a Leica TCS SP5 confocal
microscope.
The terminal deoxynucleotidyl transferase-mediated
dUTP-DIG nick end labelling (TUNEL) method to reveal cells
undergoing apoptosis was performed on fixed whole mount
embryos. Embryos were rinsed in PBS containing 0.1% Tween
(PBT), washed in PBT for 1 h and treated with 10 lg/ml Pro-
teinase K in PBT for 20 min. Embryos were then post-fixed
for 30 min in 4% formaldehyde, 0.1% glutaraldehyde in PBT,
washed for 1 h in PBT and incubated for 30 min in terminal
deoxynucleotidyl transferase (TdT) buffer (Invitrogen). This
was followed by an overnight incubation of the embryos in
TdT buffer containing 20 mM DIG-dUTP (Boehringer–Mann-
heim) and 50 U of TdT enzyme (Invitrogen) at room tempera-
ture. Embryos were washed twice in PBT for 1 h at 65 C and
four times for 1 h at room temperature. Detection of the
DIG-label was carried out following the in situ hybridisation
protocol (Streit et al., 1998).
5.3. Vectors, morpholinos and primers
The RNAi vectors pRFPRNAi C, pRFPRNAi cNotch1 and
pRFPRNAi GFP (Das et al., 2006) were supplied by ARK-Genom-
ics, UK. RNAi target finder at https://genscript.com/ssl-bin/
app/rnai was used to select target sequences for Eya2 (G/ATA-
CCTTCCTACAGCATCAAA), and Pax2 (G/TCCTCGGTCGAATG
GCGAGAA). Target sequences were cloned into the first hair-
pin site of the pRFPRNAi C silencing vector according to the
ARK-Genomics protocol. All oligoprimers used (for sequences
see protocol supplied by ARK-Genomics, UK; Das et al., 2006)
were synthesised and supplied by Invitrogen. The avian
expression vectors pCAb-IRES-mGFP/RFP (McLarren et al.,
2003) and pCAGGSmCherry/eGFP (a kind gift from K. Langen-
feld) were used as control vectors.
To down-regulate cDicer1 (NP_001035555.1), fluorescein-
coupled morpholino (ACAGCTTACAACCTTACCTGTTTAG;
Gene Tools, USA) targeting the exon 8–intron 9 boundary of
cDicer1 were used. To reveal exon 8 excision (Fig. 5C), RT-PCR
was performed using primers spanning exon 5–exon 9 (Table
2). The fluorescein-coupled standard control morpholino
(Gene Tools, USA) was used for control experiments.
Fluorescein-coupled morpholinos against Eya2 (ENS-
GALG00000004508) were designed to interfere with splicing
events at boundaries of exon 3–intron 4 (CTTGGCAGGAA-
CACTCACTTTGTTG) and exon 6–intron 7 (ATAAATGCTGAGA
TATACCTGATGC), resulting in deletion of exon 3 and exon 6,
respectively (Fig. 1A). As control sense morpholinos and the
standard control morpholino were used. RT-PCR was carried
out to reveal exon excision (Table 2). Fluorescein-coupled
Pax2 morpholinos were generated to target the exon 2–intron
3 boundary (GCGGACTCGCCCTTACCTGTTTATG, using ENSG-
ALT00000009124 Pax2 sequence) and the transcription start
site (GGTCTGCCTTGCAGTGCATATCCAT, using NM_204793
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Pax2 sequence), sense morpholinos were used as controls.
Efficient knock-down of Pax2 was assessed by Pax2 antibody
staining (Fig. 3D–H). To study expression of FGF2, p56, PIG3,
CDM2, p21 and cS17 we used primers listed in Table 2.
5.4. RT-PCR
Tissues expressing pRFPRNAi GFP, pCAb-IRES-RFP, mor-
pholinos targeting Dicer, Eya2 or standard control morpholi-
nos were excised from electroporated embryos after 16 h in
culture. Electroporated ectoderm was visualised using a fluo-
rescence stereomicroscope, freed from the underlying meso-
derm using 20 lg/ml dispase (Roche) in Tyrode’s saline and
collected in Tri-reagent. RNA was extracted using the TriPure
Isolation Kit (Roche) and reversed transcribed using random
primers (Promega). PCR was carried out using 2 ll template
and 0.3 U TaqPol (Promega) in a PTC-200 Peltier Thermal
Cycler for 2 min at 94 C, 35 cycles of 94 C for 1 min, 1 min
primer annealing temperature, and 45 s at 72 C. The final
cycle step was followed by 12 min at 72 C.
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